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Abstract 21 
 22 
Analysis of multifunctional CD4+ T cells is fundamental for characterizing the immune responses to 23 
vaccination or infections. Peptide-MHC tetrameric complexes represent a powerful technology to 24 
detect antigen-specific T cells by the specific binding to their T cell receptor, and their combination 25 
with functional assays is fundamental for characterizing the antigen-specific immune response. Here 26 
we optimized a protocol for the detection of multiple intracellular cytokines within epitope-specific 27 
CD4+ T cells identified by the MCH class II tetramer technology. The optimal procedure for assessing 28 
the functional activity of tetramer-binding CD4+ T is based on the simultaneous intracellular staining 29 
with both MHC tetramers and cytokine-specific antibodies upon in vitro restimulation of cells with 30 
the vaccine antigen. The protocol was selected among procedures that differently combined the steps 31 
of cellular restimulation and tetramer staining with intracellular cytokine labelling.  32 
This method can be applied to better understand the complex functional profile of CD4+ T cell 33 
responses upon vaccination or infection.  34 
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1. Introduction  35 
 36 
The study of the CD4+ T cell activation and effector function is fundamental in the 37 
characterization of immune responses to vaccination (1).  38 
CD4+ T cells play a central role in mediating vaccine immune responses by shaping both the 39 
humoral and cellular immunity (2). Activated CD4 T cells are critically involved in providing 40 
cognate help to B cells for production of protective antibodies, and modulate the functions of 41 
macrophages and CD8+ cytotoxic T cells through cytokines secretion. The characterization of the 42 
cytokine production of antigen-specific T cells is therefore of critical importance to profile 43 
vaccine immune response. The direct and specific method for identifying antigen-specific CD4+ 44 
T cells is based on the major histocompatibility complex (MHC) tetramer staining technique (3). 45 
This procedure allows the identification of specific T cells due to the selective and multivalent 46 
binding of tetramer MHC–peptide complexes to the T cell receptors (TCR) (3,4) and has been 47 
used for characterizing the primary and recall antigen-specific CD4+ T cell responses in many 48 
pre-clinical and human studies (1,5–9).  49 
The effector function of antigen-reactivated T cells is commonly measured by flow cytometry-50 
based intracellular cytokine staining (ICS) that allows the simultaneous phenotypic 51 
characterization and cytokine detection within single cells (10,11). The characterization of 52 
intracellular cytokines allows to identify activated CD4+ T cells capable of producing more than 53 
one cytokine, and the analysis of these multifunctional/polyfunctional cells is important for 54 
characterizing the immune response elicited by the vaccination or natural infections (12). 55 
Polyfunctional CD4+ T cells secreting IFN‐γ, TNF‐α and IL‐2 have been proposed as a major 56 
component of immune response that correlates with mouse protection against challenge with 57 
Leishmania major (13). In tuberculosis (TB), it has not been clarified if the frequency and quality 58 
of polyfunctional CD4+ T cell responses elicited in mice by different types of vaccines correlate 59 
with protective immunity (14–17), while human studies have shown that a consistent response of 60 
CD4+ T cells co-expressing IFN-γ, TNF-α and IL-2 was associated with acute TB infection (18). 61 
Tetramer labeling and intracellular cytokine staining are generally not recommended to be 62 
performed concurrently since the in vitro antigen restimulation can induce TCR internalization, 63 
thus losing the possibility of detecting epitope-specific CD4+ T cells using tetramers (19). 64 
In order to identify a protocol for the detection of intracellular cytokine production within the 65 
activated epitope-specific CD4+ T cells, we assessed different strategies that combined cellular 66 
restimulation (with the vaccine antigen or tetramers) and tetramer staining (extracellular or 67 
intracellular) with intracellular cytokine labelling. The different procedures were tested in 68 
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splenocytes from mice immunized with the chimeric tuberculosis vaccine antigen H56 (20) mixed 69 
with the adjuvant CAF01 (21), a model vaccine formulation deeply characterized in preclinical 70 
studies for its capacity of inducing both humoral and cellular responses (9,22–24). H56 is a fusion 71 
protein of M. tuberculosis antigens Ag85B, ESAT-6, and Rv2660, and the H56-specific CD4+T 72 
cell response can be monitored by employing Ag85B280–294-complexed MHC class II tetramers 73 
(8). The different procedures were tested also in another experimental setting, in which mice were 74 
immunized with the model chicken ovalbumin antigen, and the CD4+ T cell response was assessed 75 
employing tetramers specific for the epitope325-335 (25).  76 
The comparative analysis of the different protocols has permitted to optimize the procedure for 77 
identifying the multifunctional profile of tetramer-specific CD4+ T cells performing intracellular 78 
staining with both tetramers and cytokine-specific antibodies, upon antigen restimulation. This 79 
method represents a helpful tool for identifying epitope-specific CD4+ T cells and analyzing their 80 
specific effector function.  81 
  82 
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2. Materials and methods 83 
 84 
2.1 Mice  85 
Female C57BL/6 mice, purchased from Charles River (Lecco, Italy) were housed under specific 86 
pathogen-free conditions in the animal facility of the Laboratory of Molecular Microbiology and 87 
Biotechnology (LA.M.M.B.), Department of Medical Biotechnologies at University of Siena, and 88 
treated according to national guidelines (Decreto Legislativo 26/2014). The protocol was approved 89 
by the Italian Ministry of Health (authorization n° 1004/2015-PR, 22 September 2015). 90 
 91 
2.2 Immunizations 92 
Groups of 10-12 mice were immunized by the subcutaneous route at the base of the tail with the 93 
chimeric tuberculosis vaccine antigen H56 (2 µg/mouse) combined with the adjuvant CAF01 (250µg 94 
dimethyldioctadecylammonium and 50µg trehalose dibehenate/mouse, both kindly provided by 95 
Statens Serum Institut, Denmark) and boosted with a lower dose of H56 alone (0.5 µg/mouse) 4 96 
weeks later. Another experiment was performed immunizing mice with albumin from hen egg white 97 
(OVA, 25 µg/mouse, Sigma-Aldrich) combined with the adjuvant CAF01, and boosted with OVA 98 
alone. The formulations containing antigens and CAF01 were injected in a volume of 150µl/mouse 99 
of Tris 10 mM, while the formulations containing H56 and OVA alone in a volume of 100µl/mouse 100 
of 1X Dulbecco’s Phosphate Buffered Saline (1X PBS). Mice were sacrificed 5 days after boosting. 101 
 102 
2.3 Sample collection and cell preparation 103 
Spleens collected from mice were mashed onto 70µm nylon screens (Sefar Italia, Italy) and washed 104 
in complete RPMI (cRPMI) medium [RPMI (Lonza, Belgium), 100 U/ml penicillin/streptomycin, 105 
and 10% fetal bovine serum (Gibco, USA)] for 10 min at 300 g at 4°C. Splenocytes were treated with 106 
red blood cell lysis buffer (1X, eBioscience, USA) for 4 min. Following centrifugation at 300 x g at 107 
4˚C for 10 min, cells were washed with 1X PBS and counted with cell counter (Bio-Rad, USA). 108 
 109 
2.4 Protocols and reagents 110 
Six different protocols for detecting intracellular cytokines within activated epitope-specific CD4+ T 111 
splenocytes that differently combined cellular restimulation, tetramer staining and cytokine labelling, 112 
were assessed (Figure 1). Protocols were assessed in two different experimental settings, in which 113 
mice were immunized with H56 or OVA antigens, and the CD4 T cell response was analysed 114 
employing two different tetramers, specific for the H56 or OVA epitopes, respectively. 115 
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Protocol 1: Splenocytes (2x106/well) were cultured in a round-bottom 96-well plate with H56 protein 116 
(2 µg/ml) or OVA (50 g/ml), anti-CD28 and anti-CD49d costimuli (both 2 µg/ml, eBioscience) at 117 
37°C, 5%CO2 for 6h, with Brefeldin A (BFA, 5 µg/ml, Sigma-Aldrich) and monensin solution (1×, 118 
eBioscience) added during the last 5 h of incubation. Cells were washed with cRPMI for 7 min at 300 119 
g at 4°C, labelled with Fixable Viability Stain 780 staining (FVS780, BD Biosciences, 1:1000, 100 120 
µl/well) for 20 min at RT in the dark, and washed twice in PBS. Cells were fixed and permeabilized 121 
for 20 min at 4°C with BD Cytofix/Cytoperm (Becton Dickinson). Samples were blocked for 30 min 122 
at 4°C in Fc-blocking solution (5 µg/ml of CD16/CD32 mAb, eBioscience, USA) and stained for 1 h 123 
at room temperature (RT) with PE-conjugated I-A (b) M. tuberculosis Ag85B precursor 280-294 124 
(FQDAYNAAGGHNAVF) tetramer (diluted 1:80, hereafter Tet-Ag85B) or with PE-conjugated I-A 125 
(b) chicken ova 325-335 (QAVHAAHAEIN) tetramer (diluted 1:50, hereafter Tet-OVA; both 126 
tetramers were kindly provided by NIH MHC Tetramer Core Facility, Emory University, Atlanta, 127 
GA, USA) diluted in Perm/wash buffer. In the last 20 minutes of tetramer incubation, the following 128 
mix of fluorescent antibodies was added: APC-conjugated anti-CD3 (clone 145-2C11), BB700-129 
conjugated anti-CD4 (clone RM-5), APC-R700-conjugated, anti-CD44 (clone IM-7), BV786-130 
conjugated anti-IFN-γ (clone XMG1.2), BV650-conjugated anti-TNF-α (clone MP6-XT22), BV421-131 
conjugated anti-IL-17A (clone TC11-18H10), PE-CF594-conjugated anti-IL-2 (clone JES6-5H4), 132 
(all antibodies were purchased from BD Biosciences). All antibodies and tetramer were titrated for 133 
optimal dilution.  134 
Protocol 2: Splenocytes were cultured with the respective antigens and costimuli as in protocol 1, 135 
then were washed and stained with  the respective tetramers for 1h at RT. Cells were labelled with 136 
FVS780, fixed and permeabilized with BD Cytofix/Cytoperm and stained with the mix of fluorescent 137 
antibodies for 20 minutes at RT. 138 
Protocol 3: Splenocytes were stained with the respective tetramers for 1h at RT, washed and 139 
stimulated with the respective  antigens and anti-CD28 and anti-CD49d costimuli at 37°C for 6h, with 140 
Brefeldin A and monensin solution added during the last 5 h of incubation. Cells were labelled with 141 
FVS780, fixed and permeabilized with BD Cytofix/Cytoperm and stained with the mix of fluorescent 142 
antibodies for 20 minutes at RT. 143 
Protocol 4: Splenocytes were cultured with the respective tetramers and costimuli for 1h at RT, 144 
washed and added with BFA and monensin solution at 37°C for 5 h. Cells were labelled with FVS780, 145 
fixed and permeabilized with BD Cytofix/Cytoperm and stained with the mix of fluorescent 146 
antibodies for 20 minutes at RT. 147 
Protocol 5: Splenocytes were cultured with the respective tetramers and costimuli for 1h at RT and 148 
for 5h at 37°C in the presence of BFA and monensin. Cells were labelled with FVS780, fixed and 149 
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permeabilized with BD Cytofix/Cytoperm and stained with the mix of fluorescent antibodies for 20 150 
minutes at RT. 151 
Protocol 6: Splenocytes were cultured with the respective tetramers and costimuli for 6h at 37°C, 152 
with BFA and monensin during the last 4h of incubation. Cells were labelled with FVS780, fixed and 153 
permeabilized with BD Cytofix/Cytoperm and stained with the mix of fluorescent antibodies for 20 154 
minutes at RT. 155 
 156 
 157 
 158 
2.5 Flow cytometry  159 
About 7x105 stained cells from each protocol were acquired on BD™ LSRFortessa X20 flow 160 
cytometer (BD Biosciences) and stored. Data analysis was performed using FlowJo v10 (TreeStar, 161 
USA), and the evaluation of different cytokines co-expression was performed using the FlowJo 162 
Boolean gate platform. Fluorescence minus one (FMO) controls were performed for all fluorescence 163 
and used for gating setting. 164 
 165 
 166 
2.6 Statistical analysis 167 
Kruskal-Wallis test, followed by Dunn’s post test for multiple comparisons, was used to assess the 168 
statistical difference between protocols. A P value ≤ 0.05 was considered significant. Analysis were 169 
performed using GraphPad Prism v7 (GraphPad Software, USA).  170 
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3. Results  171 
 172 
In order to optimize the protocol for the detection of intracellular cytokines within activated epitope-173 
specific CD4+ T cells, we tested different procedures in splenocytes from mice parenterally 174 
immunized with two different antigens, the chimeric TB vaccine antigen H56 or OVA, combined 175 
with the liposome adjuvant CAF01, 5 days after the booster immunization. The induction of Ag-176 
specific CD4+ T cells producing cytokines was assessed combining antigen restimulation and 177 
tetramer staining, followed by intracellular cytokine detection (Figure 1). In protocols 1-3 splenocytes 178 
were restimulated with the respective antigens, added before (protocols 1 and 2) or after (protocol 3) 179 
tetramer staining. In protocols 4-6 the restimulation step was performed directly with epitope-180 
complexed MHC II tetramers, that were therefore used not only as staining tool, but also as functional 181 
stimulus. The comparison of results obtained following the different strategies, and tested with two 182 
different antigens, has permitted to optimize the procedure for identifying the cytokine profile of 183 
tetramer-specific CD4+ T cells.   184 
  185 
3.1 Identification of tetramer-specific CD4+ T cells producing cytokines 186 
H56-specific CD4+ T cells were identified using the Ag85B280–294-complexed MHC class II tetramers 187 
specific for the immunodominant epitope of Ag85B (26), which is part of the chimeric H56 protein, 188 
while OVA-specific CD4+ T cells using the chicken OVA325-335 -complexed MHC class II 189 
tetramersTetramer positive cells (Tet-Ag85B+ or Tet-OVA+) were identified as live single CD3+ 190 
CD4+ CD44+ cells, and TNF-α, IFN-γ, IL-17 and IL-2 cytokines were detected within gated Tet-191 
Ag85B+ cells. All gates were defined on the bases of the respective FMO controls. Staining specificity 192 
was determined using a control tetramer complexed with an unrelated antigen that showed a level of 193 
staining below 0.02% (data not shown). The identification of Tet-Ag85B+ cells in the different six 194 
protocols (Figure 2 A), and their intracellular cytokine production (Figure 2 B) are shown.  195 
ICS protocol typically includes an antigen stimulation step, that is crucial for activation of effector 196 
function of CD4+ T cells. Nevertheless, this step induces the internalization of TCR molecules, thus 197 
negatively impacting on the tetramer staining procedure. To overcome this limitation, we assessed a 198 
strategy based on the antigen stimulation phase followed by permeabilization and fixation of cells 199 
and subsequent tetramer staining (Figure 1, protocol #1). Using this procedure, that allows to identify 200 
both extra and intracellular TCR molecules, we detected 0.53% of Tet-Ag85B+ cells (Figure 3A, 201 
orange box). This frequency was significantly higher compared to protocol 2, in which splenocytes 202 
were firstly stimulated with H56 antigen and then labelled with the specific tetramer (Figure 1, 203 
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protocol #2) allowing an identification of only a 0.2 % of tetramer-positive T cells (Figure 3A, light 204 
green).   205 
The impact of the tetramer staining performed before antigen restimulation was also evaluated (Figure 206 
1, #3). This procedure allowed to detect a frequency of 0.37% of Tet-Ag85B+ T cells that was higher 207 
compared to protocol 2 while was lower respect to protocol 1(Figure 3A dark green box). The higher 208 
number of Tet-Ag85B+ T cells detected in protocol 1 could be due to the effect of prior antigen 209 
restimulation that is known to induce the formation of large clusters of TCR molecules thus increasing 210 
tetramer binding avidity (27).  211 
In protocols 4, 5 and 6, there was no antigen stimulation and the Ag85B280–294-complexed MHC class 212 
II tetramers were used not only for identifying but also for stimulating antigen-specific CD4+ T cells 213 
(Figure 1, protocols #4, 5 and 6). As expected, the frequencies of Tet-Ag85B+ T cells detected in 214 
protocol 4 were comparable to those of protocol 3 (Figure 3A, light blue and dark green box). In  215 
protocols 5 and 6, in which a tetramer incubation phase of 6 hours was performed, frequencies of 216 
1.07 and 1% of Tet-Ag85B+ T cells were observed, significantly higher respect to H56-stimulated 217 
samples (Figure 3A, P ≤ 0.05 and P ≤ 0.001 compared to protocols 3 and 2, respectively). A similar 218 
behavior was observed in mice immunized with the OVA antigen, in which the OVA-specific CD4+ 219 
T cells were identified using the OVA325-335 peptide-complexed tetramer (Figure 3B). This shows that 220 
tetramers with different peptide specificity, respond in a very similar way to the in vitro staining 221 
procedures assessed in the different protocols.  222 
The effector function of both Tet-Ag85B+ and Tet-OVA+ T cells identified with the different 223 
strategies, was analyzed by measuring the intracellular production of 4 different cytokines using 224 
multiparametric flow cytometry. As shown in figure 3 C and D, the highest percentage of cells 225 
producing intracellular cytokines was detected for both tetramers in protocols 1, 2 and for Tet-226 
Ag85B+ also in protocol 3, compared to protocols 4, 5 and 6. These data show that in absence of 227 
antigen stimulation, despite the high frequencies of tetramer-binding CD4+ T cells (protocols 5 and 228 
6, Figure 3 A and B), a significant lower cytokines production is induced (Figure 3 C and D) 229 
highlighting the importance of the in vitro re-stimulation step with the vaccine antigen to effectively 230 
stimulate the effector function of antigen-specific CD4+ T cells.  231 
 232 
3.2 Evaluation of tetramer-specific CD4+ T cells mutlifunctional profile. 233 
In order to have a picture of the multifunctional profiles of T cells elicited by immunization and 234 
detected by the different experimental procedures, a Boolean analysis of data was performed within  235 
Tet-Ag85B+ cells (Figure 4A). A significant amount of cells positive for all the four cytokines or for 236 
TNF-α, IFN-γ, and IL-2 were observed in protocols 1 and 3 compared to protocols 4 and 5 (P ≤ 0.05). 237 
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Cells producing only IFN-γ were instead significantly higher in protocols 5 and 6 compared to 238 
protocol 2 (P ≤ 0.01). The analysis of the frequency of cells producing two or more cytokines 239 
(multifunctional), a single one (single) or no cytokines in each protocol shows that the frequency of 240 
multifunctional Tet-Ag85B+ T cells was higher in protocols 1, 2 and 3 (79, 68, 69 % respectively) 241 
that included the antigen restimulation. Lower frequencies of multifunctional cells were observed in 242 
protocols 4, 5 and 6 (12, 7, 18 % respectively) in which most of cells did not produce any cytokine 243 
(75, 74, 68 %) (Figure 4B). The intracellular staining with the tetramer performed in protocol 1, 244 
allowed to detect the highest percentage of multifunctionality, while no differences were observed 245 
among protocols 2 and 3. Therefore the optimal strategy of staining that allows to identify 246 
multifunctional T-helper cells among tetramer-specific CD4+ T cells was the protocol #1.  247 
 248 
In conclusion, our comparative analysis, confirmed for two different antigens and their respective 249 
tetramers, has shown that the optimal strategy for identifying the multifunctional cytokine profile of 250 
tetramer-specific CD4+ T cells is the procedure #1, in which the antigen restimulation phase is 251 
followed by the intracellular tetramer staining. Indeed, this protocol allows to detect a significant 252 
amount of tetramer-specific T cells, their multifunctional activity, and it allows to reduce the staining 253 
time, by adding cytokine-specific antibodies in the last 20 minutes of tetramer incubation. A detailed 254 
description of protocol #1 is reported in Figure 5.    255 
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Discussion 256 
 257 
In this study we optimized a flow cytometric protocol for identifying at the single-cell level 258 
multifunctional epitope-specific CD4+ T cells, elicited by immunization. Demonstrating pros and 259 
cons of different protocols, we showed that the optimal procedure for the simultaneous detection of 260 
epitope-specific CD4+ T cells and their effector function is based on the antigenic stimulation of cells 261 
combined with a single step of cytokine and tetramer staining in permeabilized cells (Figure 5). Our 262 
analysis was based on the comparison of different experimental procedures, tested with two different 263 
epitope-specific tetramers, in which the steps of antigen restimulation, tetramer and cytokine staining 264 
were differently combined. The systematic analysis of different procedures performed in the same 265 
samples has offered the possibility of selecting the optimal protocol among different strategies. The 266 
results have been confirmed with tetramers specific for two different antigens, thus strengthening the 267 
possible application of the selected procedure to the characterization of the complex functional profile 268 
of CD4+ T cell responses upon vaccination or infection. 269 
Most of the studies of intracellular cytokine production within tetramer positive cells, have been 270 
conducted in CD8+ T cells (28–30), while few works have been performed in CD4+ T cells with MHC 271 
class II tetramers (31–33) and none has compared different protocols in a systematic way. Even though 272 
a direct comparison with the present study is difficult due to different experimental settings, i.e the 273 
use of T cell clones or human CD4+ T cells, prolonged incubation with antigen for cell activation, 274 
magnetic bead enrichment of tetramer positive cells before ICS staining, we can generally observe 275 
that the tetramer staining was performed extracellularly, often before the antigen stimulation step. 276 
Our analysis clearly demonstrates that antigenic stimulation is necessary for an efficient reactivation 277 
of the cellular effector function, and the same stimulation effect can not be obtained with the direct 278 
incubation of cells with epitope-complexed MHC tetramers, also when prolonged for 6 hours 279 
(protocols 5-6). Nevertheless, many studies have demonstrated that ligation of TCR by processed 280 
antigen induces TCR internalization and a subsequent down-modulation of its cell surface expression 281 
(19,34). Indeed,  in protocol 2, in which antigen stimulation was performed before the extracellular 282 
tetramer staining the frequency of tetramer positive cells was significantly lower compared to 283 
protocol 1.  284 
Here, using tetramers specific for two different antigens, we have shown the efficiency of tetramer 285 
staining performed in permeabilized cells (protocol 1) that allows to detect both surface expressed 286 
and internalized TCR molecules resulting in the identification of the highest percentages of tetramer-287 
binding cells. This procedure stained epitope-specific CD4+ T better than protocol 3 in which labeling 288 
with tetramer was performed before antigen stimulation. This can be due to the lower avidity of 289 
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tetramer binding to TCR molecules in the absence of cell activation by antigen stimulation. Indeed, 290 
cellular activation is known to induce  the TCR reorganization with the generation of large clusters 291 
of TCR molecules (27) that increase the strength of tetramer binding.  292 
Analysis of multifunctional CD4+ T cells is of critical importance for in depth characterization of 293 
immune responses to vaccination both in pre-clinical and clinical studies. It is therefore essential to 294 
have a protocol that optimally combines the identification of antigen-specific T cells with the analysis 295 
of their cytokine profile. Here, we show the possibility to combine, upon antigen stimulation, tetramer 296 
and intracellular cytokine staining in permeabilized cells allowing the identification of an higher 297 
number of polyfunctional tetramer positive CD4 T cells. The amount of cells producing all the four 298 
cytokines, or coexpressing two or three cytokines (especially TNF-α, IFN-γ, and IL-2) was indeed 299 
higher compared to the other protocols tested. Significant lower levels of multifunctional cells were 300 
observed when tetramers were used both as stimulus and as staining (protocols 4, 5 and 6). Indeed, 301 
even though a higher percentage of tetramer-binding T cells was identified by protocols 5 and 6, about 302 
70% were negative for cytokine production, respect to 14% observed in protocol 1, demonstrating 303 
that the binding of epitope-complexed MHC class II molecules to TCR in the presence of CD49d and 304 
CD28 costimuli is not sufficient for effectively reactivating multifunctional antigen-specific CD4+ T 305 
cells. 306 
The functional characterization of CD4+ T cells described by the protocols analyzed here, is 307 
particularly suitable for pre-clinical studies, in which sufficient quantity of CD4+ T cells can be easily 308 
identified in draining lymphoid organs such as lymph nodes or spleens, while in humans it is generally 309 
more complicated because the frequency of antigen-specific CD4+ T cells in blood are low and often 310 
undetectable (6). Moreover, the use of MHC tetramers requires prior knowledge of the peptide epitope 311 
and host MHC haplotype, a limitation that can be easily circumvented in inbred animals.  312 
In conclusion, in the present work we have selected an optimized protocol for identifying epitope-313 
specific CD4+ T cells and their effector function, combining antigenic stimulation of cells with the 314 
intracellular staining of TCR molecules and cytokines. Antigenic restimulation, performed at the 315 
beginning of the procedure, allows the activation of cells and elicits multiple cytokine production, 316 
but at the same time it promotes the down regulation of surface TCR expression that is resolved by 317 
the intracellular tetramer staining. This procedure allows also to reduce the total protocol time, since 318 
tetramer, surface marker and cytokine staining are combined in a single staining step. 319 
This protocol allows to better understand the complex functional profile of T cell responses upon  320 
vaccination or natural infection, and it can be instrumental for the dissecting the immune response to 321 
vaccination.  322 
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 436 
Figure 1. Study design.  Six different protocols, combining antigen stimulation and tetramer staining with 437 
intracellular cytokine labelling, were used for detecting antigen-specific CD4+ T cell producing cytokines in 438 
splenocytes of mice immunized with two different antigens, H56 or OVA,  and CAF01 adjuvant, 5 days after 439 
booster immunization. In protocols 1-3 splenocytes were restimulated with the respective antigen (Ag, pink 440 
box), added before (protocols 1 and 2) or after (protocol 3) tetramer staining (green box), while in protocols 441 
4-6 the restimulation step was performed directly with Ag85B or OVA epitope-complexed MHC II tetramers. 442 
Anti-CD28 and anti-CD49d (co-stimuli) were added with Ag (protocol 1-3) or with tetramers (protocols 4-6). 443 
After Ag or tetramer incubation, cells were treated with Brefeldin A and Monensin for 4-5 h at 37°C, fixated 444 
and permeabilized (gray box) and finally stained with anti-cytokines antibodies (dark gray box), except for 445 
protocol 1, in which tetramer staining was performed in fixed and permeabilized cells together with cytokine 446 
staining. In protocol 6, tetramer staining was performed for 2 h at 37°C.  447 
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 448 
Figure 2. Flow cytometric analysis of Tet-Ag85B+ T cells producing cytokines. A. Ag85B-tetramer 449 
binding T cells were identified among live single CD3+ CD4+, as CD44high Tet-Ag85B+ cells in the six 450 
different protocols, and the frequencies of positive cells are reported within the dot plots. B.  Intracellular 451 
production of TNFα, IFNγ, IL-17 and IL-2 cytokines assessed within the Tet-Ag85B+ T cells in the six 452 
different protocols. Frequencies of positive cells are reported within the dot plots. Gates were defined on the 453 
respective FMO controls. 454 
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 455 
Figure 3. Identification of tetramer-specific CD4+ T cells and their cytokine production. Tetramer-456 
specific CD4+ T cells and their cytokine production were assessed in splenocytes treated with the different 457 
protocols reported in Figure 1. A-B. Box plots of the frequencies of Tet-Ag85B+ (A) and Tet-OVA+ (B) T 458 
cells respect to CD4+ T cells, detected employing protocols 1-6, as reported in x axis. Values are reported as 459 
mean ± SEM of 10-12 mice, obtained in three independent experiments. Kruskal-Wallis test, followed by 460 
Dunn’s post test for multiple comparisons, was used to assess the statistical difference between protocols (*P 461 
≤ 0.05, **P ≤ 0.01, ***P ≤ 0.001). C-D. Frequencies of TNF-α, IFNγ, IL-17 and IL-2 positive cells among 462 
Tet-Ag85B+ (C) and Tet-OVA+ (D) cells, employing protocols 1-6, as reported in x axis. Values are reported 463 
as mean ± SEM of 10-12 mice, obtained in three independent experiments. The significant difference between 464 
each cytokine among the different protocols, according to the Kruskal-Wallis test followed by Dunn’s post test 465 
for multiple comparisons (P ≤ 0.05), is reported with letters above the error bars; “a”, significant difference 466 
versus protocols 4, 5 and 6; “b” versus protocol 5; “c” versus  protocols 4 and 5; “d” versus protocols 3, 5 and 467 
6; “e” versus protocol 4.  468 
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 469 
Figure 4. Multifunctional response of Tet-Ag85B+ T cells. Multifunctional profiles of Tet-Ag85B+ T cells 470 
detected by the different experimental procedures. A. Histograms represent the number of Tet-Ag85B+ T cells 471 
producing different combinations of cytokines shown on the x axis, detected employing the different protocols. 472 
Responses are grouped and color coded according to the functionality (orange for single cytokine, light blu for 473 
two or more cytokines). Values are reported as mean ± SEM of 10-12 mice, obtained in three independent 474 
experiments, and the numbers above the error bars indicate which protocols are significantly different 475 
according to the Kruskal-Wallis test, followed by Dunn’s post test for multiple comparisons (P ≤ 0.05). B. Pie 476 
charts of the 6 protocols, in which each slice of the pie represents the fraction of Tet-Ag85B+ T cells producing 477 
two or more cytokines (multiple cytokines, light blue), a single one (orange) or none (grey).  Frequencies are 478 
reported within each slice.  479 
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 480 
Figure 5. Optimal procedure for identifying multifunctional tetramer-specific CD4+ T cells. Schematic 481 
overview of the protocol optimized for the detection of multifunctional epitope-specific CD4+ T cells. 482 
Splenocytes are cultured in 96-well plates with antigen and costimuli for 1h at 37°C in order to allow antigen 483 
presentation by APC to cognate epitope-specific CD4+ T cells. Antigen stimulation elicits reactivation of 484 
effector function of CD4+ cells, and TCR internalization. Brefeldin A (BFA) and monensin solution are added 485 
for the last 5 h of incubation to block cytokines secretion. Cells are fixed and permabilized for 20 min at 4°C, 486 
and then simultaneously stained with MHC II tetramers (1 h, at RT) and surface markers/cytokine-specific 487 
antibodies (last 20 minutes). This allows to detect both surface expressed and internalized TCR molecules, 488 
with intracellular cytokines. The single-step staining procedure allow to reduce the complex time of the 489 
protocol. Stained samples are then analysed by flow cytometry.  490 
